Nijmegen, the Netherlands – June 20, 2022 – We are pleased to announce the onboarding of Marcus Conradt as new COO at Vaxxinova, as of Monday June 20.Member of the Global Management Team, Marcus will be responsible for the coordination of production and R&D within Vaxxinova. Marcus is an experienced leader with proven management capabilities. […]
Bergen, Norway – April 1, 2022 – The Business Unit Aqua from Vaxxinova announces that starting April 1, 2022, Dr. med. vet Sandra Arcos Peña will be the Technical and Commercial Director for Vaxxinova Chile. Sandra will report to the BU Aqua Manager (Matias del Campo) and will be responsible for the LATAM cold-water […]
Nijmegen, NL – January 17, 2022 – Vaxxinova proudly presents its brand new corporate video. It gives an impression on our commitment to animal health, animal welfare and one health. Vaxxinova, we care.
Worthington, MN – Sept. 30, 2021 – Vaxxinova announced today that it has purchased Newport Laboratories, a company that manufactures custom-made vaccines for swine and cattle, from Boehringer Ingelheim. About 100 people work at Newport Laboratories in Worthington, Minnesota. They help veterinarians and livestock producers address animal health issues through diagnostic testing and production of […]
May 6, 2021 – Cuxhaven, Germany On May 27th, 2021 at 4 PM CET Dr. Heike Bigmore, KAM with Vaxxinova Autogenous Vaccines GmbH, will talk about the use of autogenous vaccines as a tool in disease control and mitigation of antimicrobial resistance (AMR) in animal production. The webinar, hosted by EW Nutrition, is titled Autogenous […]
March 15, 2021 – Wilmar, MN, USA Vaxxinova US is announcing USDA approval of their new Vaxxon® SRP® Pasteurella vaccine. Categorized by USDA as a Pasteurella Multocida Bacterial Extract, it is an effective, innovative and safe vaccine against fowl cholera in chickens. Vaxxon SRP Pasteurella provides the industry a new category for long-term protection of […]
Dec 16, 2020 – Wilmar, MN, USA Vaxxinova US has acquired marketing rights from Zoetis for a vaccine against Salmonella in cattle. Until now, the SRP Salmonella vaccine – the first USDA-licensed vaccine to use SRP technology – was manufactured by Vaxxinova US but marketed by Zoetis. With the latest license acquisition, Vaxxinova US now […]
Dutch farmers Magazine “Boerderij” published an article on autogenous vaccines in its June 16, 2020 edition. The article mentions how autogenous vaccines can contribute to reduced antibiotic use in swine and Vaxxinova’s contribution to this. Read the full article here.
Nijmegen, The Netherlands, Wednesday June 3, 2020. Vaxxinova® Nederland BV is pleased to announce two new directors to its team as per June 1, 2020. Both positions are based in Nijmegen. Mrs. Mirjam van der Sluijs will take up the role of Director R&D Nijmegen. As Director R&D Nijmegen Mirjam will lead the R&D and […]
Nijmegen, The Netherlands, Tuesday June 2, 2020. Vaxxinova® International announces that starting June 1, 2020, Dr. Matias del Campo will be the Managing Director for Vaxxinova Norway and Vaxxinova Chile. Matias will be responsible for the global cold-water aquaculture business. Matias is an Aquaculture Engineer from the University Andres Bello in Chile and holds a […]